Richard E. Gilbert
Richard E. Gilbert
University of Melbourne, St. Michael's Hospital, Austin, Guy's
Dirección de correo verificada de utoronto.ca
TítuloCitado porAño
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
RE Gilbert, ME Cooper
Kidney international 56 (5), 1627-1637, 1999
7201999
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
ME Cooper, D Vranes, S Youssef, SA Stacker, AJ Cox, B Rizkalla, ...
Diabetes 48 (11), 2229-2239, 1999
5681999
Writing Group Members; American Heart Association Statistics Committee; Stroke Statistics Subcommittee
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Heart disease and stroke statistics-2016 update: a report from the American …, 2016
408*2016
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical …
MA Pohl, S Blumenthal, DJ Cordonnier, F De Alvaro, G DeFerrari, ...
Journal of the American Society of Nephrology 16 (10), 3027-3037, 2005
4062005
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ...
Canadian Journal of Cardiology 31 (5), 549-568, 2015
3642015
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ...
Canadian Journal of Cardiology 32 (5), 569-588, 2016
3452016
Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
RE Gilbert, A Cox, LL Wu, TJ Allen, UL Hulthen, G Jerums, ME Cooper
Diabetes 47 (3), 414-422, 1998
3351998
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ...
Canadian Journal of Cardiology 30 (5), 485-501, 2014
3022014
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition
R Langham, D Kelly, A Cox, N Thomson, H Holthöfer, P Zaoui, N Pinel, ...
Diabetologia 45 (11), 1572-1576, 2002
2732002
Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy
A Tzanidis, RD Hannan, WG Thomas, D Onan, DJ Autelitano, F See, ...
Circulation research 93 (3), 246-253, 2003
2682003
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ...
Canadian Journal of Cardiology 26 (5), 249-258, 2010
2662010
Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
LL Wu, A Cox, CJ Roe, M Dziadek, ME Cooper, RE Gilbert
Kidney international 51 (5), 1553-1567, 1997
2591997
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.
JR Rumble, ME Cooper, T Soulis, A Cox, L Wu, S Youssef, M Jasik, ...
The Journal of clinical investigation 99 (5), 1016-1027, 1997
2541997
Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale …
SJ Haas, T Vos, RE Gilbert, H Krum
American heart journal 146 (5), 848-853, 2003
2532003
Retinal neovascularization is prevented by blockade of the renin-angiotensin system
CJ Moravski, DJ Kelly, ME Cooper, RE Gilbert, JF Bertram, S Shahinfar, ...
Hypertension 36 (6), 1099-1104, 2000
2482000
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ...
Canadian Journal of Cardiology 29 (5), 528-542, 2013
2432013
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II–therapy
NA Khan, FA McAlister, SW Rabkin, R Padwal, RD Feldman, ...
Canadian Journal of Cardiology 22 (7), 583-593, 2006
241*2006
The (Pro)Renin Receptor: Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney
A Advani, DJ Kelly, AJ Cox, KE White, SL Advani, K Thai, KA Connelly, ...
Hypertension 54 (2), 261-269, 2009
2302009
Increased plasma urotensin II levels in patients with diabetes mellitus
K TOTSUNE, K TAKAHASHI, Z ARIHARA, M SONE, S ITO, O MURAKAMI
Clinical science 104 (1), 1-5, 2003
2292003
Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury
T Soulis, V Thallas, S Youssef, RE Gilbert, BG McWilliam, ...
Diabetologia 40 (6), 619-628, 1997
2291997
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20